Production (Stage)
PureTech Health plc
PTCHF
$1.68
$0.031.82%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2,422.22% | 2,422.22% | -90.86% | -90.86% | -97.90% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2,422.22% | 2,422.22% | -90.86% | -90.86% | -97.90% |
| Cost of Revenue | -27.56% | -27.56% | -26.75% | -26.75% | -38.35% |
| Gross Profit | 38.15% | 38.15% | 22.71% | 22.71% | 29.73% |
| SG&A Expenses | 61.12% | 61.12% | 6.08% | 6.08% | -27.36% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.33% | 7.33% | -15.92% | -15.92% | -34.45% |
| Operating Income | -1.01% | -1.01% | 12.82% | 12.82% | 28.81% |
| Income Before Tax | 452.44% | 452.44% | -300.43% | -300.43% | 39.28% |
| Income Tax Expenses | -88.57% | -88.57% | -152.06% | -152.06% | 180.56% |
| Earnings from Continuing Operations | 286.64% | 286.64% | -91.33% | -91.33% | -202.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4,735.58% | 4,735.58% | 1,202.38% | 1,202.38% | 104.57% |
| Net Income | 334.15% | 334.15% | -67.07% | -67.07% | -84.88% |
| EBIT | -1.01% | -1.01% | 12.82% | 12.82% | 28.81% |
| EBITDA | -1.88% | -2.23% | 11.65% | 11.65% | 29.20% |
| EPS Basic | 368.33% | 368.33% | -72.61% | -72.61% | -89.77% |
| Normalized Basic EPS | 69.64% | 69.64% | 19.93% | 19.93% | -155.22% |
| EPS Diluted | 358.38% | 358.38% | -72.22% | -72.22% | -88.47% |
| Normalized Diluted EPS | 70.00% | 70.00% | 19.93% | 19.93% | -155.22% |
| Average Basic Shares Outstanding | -12.79% | -12.79% | -3.09% | -3.09% | -2.63% |
| Average Diluted Shares Outstanding | -11.65% | -11.65% | -3.09% | -3.09% | -2.63% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |